About BBM
Technology & Platform
Media Center
Investor Relations
Careers
Contact Us
CN
搜索
菜单
About BBM
Technology & Platform
Media Center
Investor Relations
Careers
Contact US
Media Center
Special report 2023: Meet 20 women reshaping biopharma
2023年07月21日
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A
上一篇
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
下一篇